1.35%| Prev Close: | 23.06 |
|---|---|
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 28.00 |
| Beta: | 1.75 |
| Next Earnings Date: | N/A |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 8.00 - 31.15 |
| Volume: | 0 |
| Avg Vol (3m): | 33,009 |
| Market Cap: | 619.05M |
| P/E (ttm): | 13.50 |
| EPS (ttm): | 1.71 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- China Biologic: A Star Small-Cap Pick From Chinaat Seeking Alpha(Thu, Jun 13)
- China Biologic Waived Application of Preferred Shares Rights AgreementPR Newswire(Mon, Jun 10)
- CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Material Modification to Rights of Security HoldersEDGAR Online(Sun, Jun 9)
- High Growth Chinese Stocks With Strong Trends In Accounts Receivable And Inventoryat Seeking Alpha(Thu, Jun 6)
- SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of China Biologic Products, Inc.PR Newswire(Mon, Jun 3)
- China Biologic Updates the Hong Kong Litigation in respect of the Shares Held by Ms. Siu Ling ChanPR Newswire(Mon, Jun 3)
- CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Material Modification to Rights of Security HoldersEDGAR Online(Thu, May 30)
- China Biologic Comments on the Proposed Shanghai RAAS TransactionPR Newswire(Fri, May 24)
- CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements anEDGAR Online(Fri, May 17)
- CHINA BIOLOGIC PRODUCTS, INC. FinancialsEDGAR Online Financials(Wed, May 15)
- China Biologic Reports Financial Results for the First Quarter of 2013PR Newswire(Wed, May 8)
- CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Wed, May 8)
- CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 8)
- China Biologic Products to Report First Quarter 2013 Financial ResultsPR Newswire(Thu, May 2)
- A Cautious Outlook on the Cell Therapy Space: Expert Analyst Boris Peaker Interviews with The Wall Street Transcript and Discusses Challenges in Bringing Patients to Clinical StudiesWall Street Transcript(Wed, May 1)
Press Releases
- China Biologic Waived Application of Preferred Shares Rights AgreementPR Newswire(Mon, Jun 10)
- SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of China Biologic Products, Inc.PR Newswire(Mon, Jun 3)
- China Biologic Updates the Hong Kong Litigation in respect of the Shares Held by Ms. Siu Ling ChanPR Newswire(Mon, Jun 3)
Reports
- ValuEngine Industry Report for Medical-biomed/geneticsValuEngine, Inc.(Jun 19)
- CBPO - China Biologic Products Inc - Upgraded to a Buy - Company Analysis and...Alpha Street Research(Jun 18)
- CHINA BIOLOGIC PRODUCTS INC (CBPO) - REPORT FOR ACTIVE TRADERSPechala's Reports(Jun 17)